Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System

Genome editing of human cluster of differentiation 34(+) (CD34(+)) hematopoietic stem and progenitor cells (HSPCs) holds great therapeutic potential. This study aimed to optimize on-target, ex vivo genome editing using the CRISPR-Cas9 system in CD34(+) HSPCs and to create a clear workflow for precis...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapiro, Jenny, Iancu, Ortal, Jacobi, Ashley M., McNeill, Matthew S., Turk, Rolf, Rettig, Garrett R., Amit, Ido, Tovin-Recht, Adi, Yakhini, Zohar, Behlke, Mark A., Hendel, Ayal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251314/
https://www.ncbi.nlm.nih.gov/pubmed/32478125
http://dx.doi.org/10.1016/j.omtm.2020.04.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251314/
https://www.ncbi.nlm.nih.gov/pubmed/32478125
http://dx.doi.org/10.1016/j.omtm.2020.04.027

Ejemplares similares